Microdebrider Assisted Endoscopic Sinus Surgery Versus Conventional Endoscopic Sinus Surgery in Management of...

Introducing powered instrumentation causes drastically changes regarding the endoscopic sinus surgery performance. Such technology has a particular usage in treating different forms of CRS with nasal polyposis. In the therapy of sinonasal polyposis, we report the accuracy of surgery with a microdebrider to typical endoscopic sinus surgery instruments. A prospective randomized comparative investigation has been carried out at Al Azhar University Hospital-ENT department, involving 80 patients who were radiologically and clinically diagnosed with bilateral sinonasal polyposis. These patients had not exhibited improvement with previous medical treatments. The diagnosed cases were equally allocated into two groups, Group A (microdebrider group), who underwent microdebrider, and Group B (conventional Group), who underwent surgery with traditional equipment (Messerklinger approach). The intraoperative blood loss differs significantly among the two groups. In Group A, intraoperative blood loss seems to be much lower in individuals who had FESS with the use of a Microdebrider. Group A had mean surgery duration of 130 min, while Group B had a mean surgery time of 163 min. In the treatment of sinonasal polyposis, a microdebrider has some advantages over Conventional endoscopic sinus surgery. For people with sinonasal polyposis, powerful endoscopic sinus surgery is a preferable therapy option. It creates a dry operating field allowing better visualization and cuts down on operative duration. The current study shows that while these tools may be beneficial, they are not required for successful Functional Endoscopic Sinus Surgery (FESS) outcomes.